Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation

Transplantation

Volumn 97, Issue 1, 2014, Pages 71-77

  Park, Min Su ^a   Lee, Kwang Woong ^a   Suh, Suk Won ^a   You, Tae ^a   Choi, Youngrok ^a   Kim, Hyeyoung ^a   Hong, Geun ^a   Yi, Nam Joon ^a   Kwon, Choon Hyuck David ^b   Joh, Jae Won ^b   Lee, Suk Koo ^b   Suh, Kyung Suk ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Deceased donor liver transplantation; Hepatocellular carcinoma; Living donor liver transplantation; Recurrence

Indexed keywords

EID: 84892988825     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182a68953     Document Type: Article

References (15)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893.
2. Cheng SJ, Pratt DS, Freeman RB Jr, et al. Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis. Transplantation 2001;72: 861.
3. Sandhu L, Sandroussi C, Guba M, et al. Living donor liver transplantation versus deceased donor liver transplantation for hepato-cellular carcinoma: comparable survival and recurrence. Liver Transpl 2012; 18: 315.
4. Lo CM, Fan ST, Liu CL, et al. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007; 94: 78.
5. Fisher RA, Kulik LM, Freise CE, et al. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 2007; 7: 1601.
6. Kulik L, Abecassis M. Living donor liver transplantation for hepato-cellular carcinoma. Gastroenterology 2004; 127: S277.
7. Vakili K, Pomposelli JJ, Cheah YL, et al. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival. Liver Transpl 2009; 15: 1861.
8. Man K, Lo CM, Xiao JW, et al. The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation. Ann Surg 2008; 247: 1049.
9. Shi JH, Huitfeldt HS, Suo ZH, et al. Growth of hepatocellular carcinoma in the regenerating liver. Liver Transpl 2011; 17: 866.
10. Efimova EA, Glanemann M, Liu L, et al. Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepa-tocellular carcinoma cell lines. Eur Surg Res 2004; 36: 300.
11. Yokoi H, Isaji S, Yamagiwa K, et al. Donor outcome and liver regeneration after right-lobe graft donation. Transpl Int 2005; 18: 915.
12. Moon JI, Kwon CH, Joh JW, et al. Safety of small-for-size grafts in adult-to-adult living donor liver transplantation using the right lobe. Liver Transpl 2010; 16: 864.
13. Man K, Fan ST, Lo CM, et al. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg 2003; 237: 256.
14. Yang ZF, Poon RT, Luo Y, et al. Up-regulation of vascular endothelial growth factor (VEGF) in small-for-size liver grafts enhances macrophage activities through VEGF receptor 2-dependent pathway. J Immunol 2004; 173: 2507.
15. Hwang S, Lee SG, Ahn CS, et al. Small-sized liver graft does not increase the risk of hepatocellular carcinoma recurrence after living donor liver transplantation. Transplant Proc 2007; 39: 1526.